author-photo

Shu-Yi Hsieh

National Health Research Institutes

4

Papers

47

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer.

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (13)
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)

2013 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (13)
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)

2011 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (15)